BHC vs. TLRY, CRON, WEED, DNTL, SIA, WELL, GUD, ACB, OGI, and CPH
Should you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Tilray Brands (TLRY), Cronos Group (CRON), Canopy Growth (WEED), dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Organigram (OGI), and Cipher Pharmaceuticals (CPH). These companies are all part of the "medical" sector.
Tilray Brands (TSE:TLRY) and Bausch Health Companies (TSE:BHC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership, community ranking and earnings.
In the previous week, Tilray Brands had 1 more articles in the media than Bausch Health Companies. MarketBeat recorded 4 mentions for Tilray Brands and 3 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 0.78 beat Tilray Brands' score of 0.05 indicating that Tilray Brands is being referred to more favorably in the media.
Bausch Health Companies received 39 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 66.10% of users gave Bausch Health Companies an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.
Tilray Brands has a beta of 2.38, suggesting that its stock price is 138% more volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.
Tilray Brands presently has a consensus target price of C$2.95, suggesting a potential upside of 9.67%. Bausch Health Companies has a consensus target price of C$9.00, suggesting a potential downside of 2.39%. Given Bausch Health Companies' higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies.
10.5% of Tilray Brands shares are held by institutional investors. Comparatively, 80.9% of Bausch Health Companies shares are held by institutional investors. 1.3% of Tilray Brands shares are held by insiders. Comparatively, 0.9% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Tilray Brands has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Bausch Health Companies has a net margin of -5.07% compared to Bausch Health Companies' net margin of -47.35%. Bausch Health Companies' return on equity of -9.69% beat Tilray Brands' return on equity.
Summary
Tilray Brands beats Bausch Health Companies on 10 of the 16 factors compared between the two stocks.
Get Bausch Health Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bausch Health Companies Competitors List
Related Companies and Tools
